Indian pharmaceutical industry overview

Introduction

Where do Indian pharma industry stand today?

Indian pharmaceutical sector accounts for about 2.4% of the worldwide pharmaceutical industry in term of value and 10% in terms of volume and is expected to grow at annual growth rate of 15.92%.

Generic drug market is the largest segment of the Indian pharmaceutical sector with 71% market share. India is also the 3rd largest global generic active pharmaceutical ingredient trading market.

According to equity master report,the Indian pharmaceutical market is the 5th largest in terms of volume and 13th largest in terms of value. India is the largest generic drugs provider globally. Indian generics account for 20% of global exports in terms of volume. India plays an important position in the global pharmaceutical sector.the country has a large pool of potential scientist and engineers who can steer the industry ahead to an even higher level.

presently around 80% of the Antiretroviral drugs used globally to fight against AIDS or supplied by Indian pharmaceutical firms.The Indian pharma industry is expected to grow over 15% per annul between 2015 and 2020, will out perform the worldwide pharma industry,which is set to grow at a yearly rate of 5 between this period .the market is relied upon to grow to US dollar 55 billion by 2020,there by raising as the 6^th biggest pharmaceutical market worldwide by total size by Mr. Arun singh ,Indian ambassador to the US. Branded generics dominate the pharmaceutical markets ,constituting nearly 80% of the market share (in terms of revenue).

Growth forecast of Indian pharma industry

The sector is expected to create 58 thousand plus job opportunities by 2025 . According to PHARMEXCIL report Indian pharmaceutical export generated USD 16.4 billion in 2016-17 and also expecting the growth rate of 30% by 2020. India's biotechnology industry includes bio services,bio-pharmaceuticals .bioinformatics,bio agriculture and bio industry is expected to grow by 30% annually and reach USD 100 billion by 2025.